Justera Health Announces Closing of Debt Settlement Agreement
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has closed a previously announced debt settlement agreement. The company settled a $355,570 debt owed to a non-arm's-length creditor by issuing 7,111,400 Units at a deemed price of C$0.05 per Unit. Each Unit comprises one Common share and one Share Purchase Warrant, exercisable at $0.05 per share for an additional Common share, valid for 5 years. The warrants include an acceleration clause for forced exercise if the company's shares trade at or above $0.10 for 5 consecutive trading days on the CSE. The issued securities will be subject to a four-month and one-day hold period from the date of issuance.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) ha chiuso un accordo di liquidazione del debito precedentemente annunciato. L'azienda ha risolto un debito di $355.570 dovuto a un creditore non indipendente emettendo 7.111.400 Unità a un prezzo stimato di C$0,05 per unità. Ogni unità comprende una azione ordinaria e un warrant per l'acquisto di azioni, esercitabile a $0,05 per azione per un'ulteriore azione ordinaria, valido per 5 anni. I warrant includono una clausola di accelerazione per l'esercizio forzato se le azioni dell'azienda scambiano a $0,10 o superiore per 5 giorni di negoziazione consecutivi sulla CSE. I titoli emessi saranno soggetti a un periodo di blocco di quattro mesi e un giorno dalla data di emissione.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) ha cerrado un acuerdo de liquidación de deuda previamente anunciado. La compañía liquidó una deuda de $355,570 debida a un acreedor no independiente mediante la emisión de 7,111,400 Unidades a un precio considerado de C$0.05 por unidad. Cada unidad consta de una acción común y un warrant de compra de acciones, ejercitable a $0.05 por acción para una acción común adicional, válido por 5 años. Los warrants incluyen una cláusula de aceleración para el ejercicio forzado si las acciones de la empresa se negocian a $0.10 o más durante 5 días de negociación consecutivos en la CSE. Los valores emitidos estarán sujetos a un período de retención de cuatro meses y un día desde la fecha de emisión.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF)는 이전에 발표된 부채 조정 협상을 마무리했다. 회사는 비독립적 채권자에게 진 부채 $355,570을 해결하기 위해 7,111,400 유닛을 C$0.05의 평가 가격으로 발행했다. 각 유닛은 하나의 보통주와 하나의 주식 매입 워런트로 구성되며, 이는 보통주 하나에 대해 $0.05에 행사할 수 있으며, 유효 기간은 5년이다. 워런트에는 회사의 주식이 CSE에서 연속 5거래일 동안 $0.10 이상으로 거래될 경우 강제 행사할 수 있는 가속화 조항이 포함되어 있다. 발행된 증권은 발행일로부터 4개월 1일의 보유 기간을 가진다.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) a clôturé un accord de règlement de dette précédemment annoncé. La société a réglé une dette de $355,570 due à un créancier non indépendant en émettant 7,111,400 unités à un prix estimé de C$0,05 par unité. Chaque unité comprend une action ordinaire et un bon de souscription d'actions, exerçable à $0,05 par action pour une action ordinaire supplémentaire, valable pendant 5 ans. Les bons de souscription comprennent une clause d'accélération pour un exercice forcé si les actions de l'entreprise se négocient à $0,10 ou plus pendant 5 jours de bourse consécutifs sur la CSE. Les titres émis seront soumis à une période de blocage de quatre mois et un jour à partir de la date d'émission.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) hat ein bereits angekündigtes Schuldenbereinigungsabkommen abgeschlossen. Das Unternehmen hat eine Schuld von $355.570, die an einen nicht unabhängigen Gläubiger geschuldet wird, beglichen, indem 7.111.400 Einheiten zu einem angenommenen Preis von C$0,05 pro Einheit ausgegeben wurden. Jede Einheit besteht aus einer Stammaktie und einem Bezugsrecht auf eine Aktie, das für $0,05 pro Aktie für eine zusätzliche Stammaktie ausübbar ist und 5 Jahre gültig ist. Die Bezugsrechte beinhalten eine Beschleunigungsklausel für die erzwungene Ausübung, wenn die Aktien des Unternehmens an 5 aufeinanderfolgenden Handelstagen an der CSE bei oder über $0,10 gehandelt werden. Die ausgegebenen Wertpapiere unterliegen einer Haltefrist von vier Monaten und einem Tag ab dem Ausgabedatum.
- Debt reduction of $355,570 through shares-for-debt settlement
- Issuance of 7,111,400 Units at C$0.05 per Unit, potentially improving liquidity
- Warrants included in the Units provide potential for future capital influx
- Dilution of existing shareholders' ownership due to issuance of new shares
- Debt settlement with non-arm's-length creditor may raise concerns about related party transactions
TORONTO, ON / ACCESSWIRE / October 21, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce that it has closed previously announced shares for debt settlement transactions (see press release dated October 4, 2024). An aggregate of
About Justera Health
Established in 2020, Justera is a Canadian company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.
For additional information on Justera Health and other corporate information, please visit the Company's website at https://www.justerahealth.com/
For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.
For further information:
Investor Relations & Communications
Paul Haber, CFO
Tel: (416) 318-6501
Email: info@justerahealth.com
Forward-Looking Statements:
Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions.All statements included herein, other than statements of historical fact, are forward-looking statements, including but not limited to: the terms, timing and completion of the Transaction, if the Transaction is to close at all, the receipt of all necessary regulatory and CSE approvals, authorizations and consents in connection with the Transaction, and the completion or waiver, as applicable, of all conditions precedent required for the completion of the Transaction; the anticipated business plans, management structure, and future activities of the Company and Port North, including the Company's intention to integrate Port North into its business; and the anticipated benefits and synergies to be derived from the Transaction on the business of both Port North and the Company; and the date in which the Payment Shares may become free-trading.
Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: (i) successful completion of the Financing; (ii) successful completion of the Transaction and the integration of the business of Port North in connection therewith; (iii) the ability to manage anticipated and unanticipated costs; (iv) achieving the anticipated results of the Company's strategic plans; (v) obtaining and maintaining all required licenses, approvals and permits, including regulatory approvals required to complete the Transaction; and (vi) general economic, financial market, regulatory and political conditions in which the Company operates.
Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of the inability of Port North to complete the Financing, the inability to consummate the Transaction, including the inability to obtain required regulatory approvals and third-party consents and the satisfaction of other conditions, inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; changes in general economic, business and political conditions, including changes in the financial markets, changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera's strategic growth plans, and other factors, many of which are beyond the control of Justera.
Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera's expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
###
SOURCE: Justera Health Ltd.
View the original press release on accesswire.com
FAQ
What is the total value of debt settled by Justera Health (SCRSF) in this transaction?
How many Units did Justera Health (SCRSF) issue to settle the debt?
What is the exercise price of the Share Purchase Warrants issued by Justera Health (SCRSF)?
What is the acceleration clause for the warrants issued by Justera Health (SCRSF)?
